Product Description
Cagrilintide / semaglutide, ua lag luam raws li CagriSema, yog kev sib xyaw ua ke ntawm cagrilintide, dual amylin thiab calcitonin receptor agonist, thiab semaglutide, GLP-1 agonist. Kev kho mob ntshav qab zib hom II.
CagriSema tab tom tshawb nrhiav los kho mob ntshav qab zib hom 2 thiab rog rog. Cov txiaj ntsig kev sim ua ntej pom qhov poob qis dua piv rau semaglutide lossis cagrilintide ib leeg. HbA1c tau txhim kho zoo dua piv rau cagrilintide ib leeg thiab tsis yog - zoo dua li semaglutide ib leeg. Hauv Phase II sim, qhov hnyav poob nruab nrab -15.6 feem pua tom qab 32 lub lis piam, piv rau kev ua tau zoo rau tirzepatide.
CagriSema tau nkag mus rau Phase III kev sim tshuaj hauv xyoo 2023. Cov tshuaj tau cuam tshuam nrog qhov nruab nrab 15.1% poob phaus hauv 12 lub lis piam.
Peb lub Hoobkas
Kev xa khoom thiab kev thauj mus los
Cim npe nrov: cagrisema 5+5mg 10+10mg compound 10 vials hmoov, Tuam Tshoj cagrisema 5+5mg 10+10mg compound 10 vials hmoov lwm tus neeg, Hoobkas
